The newly developed and very smoothly and successfully running company dealing the matters concerning biotechnology that has been given the name Midatech Pharma also known as in abbreviated form PLC. This company basically deals with the research and development department which is seen to be having their focus on providing the patients with the products that would include medical tablets , syrups, injections, drips and a lot of other products that would be innovative and creatively formed with having the main idea of treating and hopefully curing the diseases regarding to the department of oncology and also most probably involving into the cure of many other rare disease that occur to patients every once in a while. Because of the efforts made by this biotechnology company day and night they have been allowed to receive funding precisely of euro 6.6 million. This funding program that has been launched by the government of Spain is given the name of the Reindustrialisation program with the cause of supporting the facility of the manufacturing department of the company in the city of Bilbao that is located in the beautiful country of Spain. Due to this generous funding act of the government of the country of Spain, now the total; public funding has summed up to be equal to the number of approximate Euros 8.5 million. This sum is inclusive of the grant and the amount of loan that had been very recently gotten approved by the regional government of Basque.
Because of the funding, a lot of improvements have been made in the company. Many hurdles and obstacles that had been intruding on the progress and the development of this biotechnology company have now been put aside and also resolved due to the funds and loans provided to the company. Further to the announcement of 29 March 2019 (the “Loan Announcement”), the Loan has to aid activities to raise the manufacturing ability of Midatech’s key development product.